WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 15-Jul-2018 (data as of 15-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 52'5901 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 50'0701 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 9'911  9'838  9'764  9'689  9'615  8'882  8'567  8'316 
Births 121  120  119  117  116  91  117  93 
Surviving infants 121  120  118  117  116  91  116  93 
Pop. less than 5 years 590  584  587  581  574  464  553  488 
Pop. less than 15 years 1'738  1'712  1'689  1'654  1'618  1'636  1'536  1'629 
Female 15-49 years 2'155  2'157  2'158  2'157  2'156  1'983  2'049  1'902 

Number of reported cases

(Click for retrospective incidence data for Sweden)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  41  22  26  51  59  29  1'786 
Mumps
ChartChart
  32  22  23  21  44  37 
Pertussis
ChartChart
  805  679  603  703  237  2'705  10'697  5'221 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sweden)
Vaccine year result method % card seen                                                
BCG          25  26  24  26  27  16  13 
DTP1         
DTP3          97  98  98  98  98  99  99 
DTP4         
IPV1         
HepB_BD         
HepB3          76  67  53  42  35 
Hib3          97  98  98  98  98  98 
JapEnc         
MCV1          97  97  98  97  97  91  96  88 
MCV2          95  95  95  95  95  94 
MenA         
PCV1         
PCV2         
PCV3          97  97  97  98  98 
Pol3          97  98  98  98  98  99  99  97 
Rota1         
RotaC         
RCV1          97  97  98  97  97 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sweden)
BCG
ChartChart
  25  25  25  25  26  16  13 
DTP1
ChartChart
  99  99  99  99  99  99  99  99 
DTP3
ChartChart
  97  97  97  97  98  99  99  99 
HepB3
ChartChart
  76  76  76  76  67 
HepB_BD
 
Hib3
ChartChart
  97  97  97  97  98  98 
MCV1
ChartChart
  97  97  97  97  97  91  96  88 
MCV2
ChartChart
  95  95  95  95  95  94 
PCV3
ChartChart
  96  96  96  96  97 
Pol3
  97  97  97  97  98  99  99  97 
RCV1
ChartChart
  97  97  97  97  97  91  96 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 290  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 97
From 80 to 89% 3
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-6 months; Yes risk groups
DTaPHibHepBIPV 3, 5, 12 months; Yes
DTaPHibHepIPV 3, 5, 12 months; Yes
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 5 years; Yes
HepB_Pediatric birth; 1 month; Yes children to HBsAg+ mothers (following doses are given as DTP-IPV-Hib-HepB at M3, M5 and M12)
HPV 10-12 years (x2); Yes females only
Influenza_Adult >=65 years; Yes and adults with chronic illness, pregnant women, health care workers, other risk groups
Influenza_Pediatric Yes children with chronic illness
MMR 18 months; 6-8 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Pneumo_ps >65 years; No and medical risk groups
Rotavirus No 10/21 counties
Tdap 14-16 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 290  290  290  290  290  290  290 
Nº districts with DTP3 coverage >=80% number 288  275  290  290  290  290  290 
% of districts with DTP3 coverage >=80% From 0 to 100% 99  95  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 260  230  281  263  267  251  244 
% of districts with MCV1 coverage >=95% From 0 to 100% 90  79  97  91  92  87  84 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No  No  No 

Sources

 1  "The 2018 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.